RESUMO
BACKGROUND: Resilience is both the individuals' capacity to navigate their way to the resources that sustain their well-being in the context of exposure to adversity and their capacity to negotiate for resources to be accessed. Hence, it is crucial for clinical settings and research centers to have access to a valid and reliable scale that can measure different components of resilience. This study aimed to determine the psychometric properties and cultural adaptation of the Persian version of the Child and Youth Resilience Measure-revised (CYRM-R) in Children. MATERIALS AND METHODS: This cross-sectional study includes the standard procedure of translation of the CYRM-R and Person Most Knowledgeable-Child and Youth Resilience Measure-revised (PMK-CYRM-R), exploration of the goodness-of-fit, and confirmatory factor analysis (CFA) of a sample of 200 parents or caregivers and their children aged 5 to 9 years who were selected by convenient sampling in Tehran, Iran. CYRM-R, PMK-CYRM-R, and The Strengths and Difficulties Questionnaire (SDQ) were completed by participants. Also, internal consistency, face, content, and criterion validity were investigated. RESULTS: A two-factor structure of CYRM-R for Iranian children was identified by CFA: Personal and Caregiver. Results indicated adequate goodness-of-fit and strong internal consistency (Cronbach's alpha = 0.88). Acceptable face, content, and criterion validity of the CYRM-R were reported by positive correlation to the PMK-CYRM-R. No significant relation was found between CYRM-R and SDQ. CONCLUSION: Findings of the present study support the robust psychometric properties and cultural adaptation of the CYRM-R in Iranian children.
RESUMO
BACKGROUND: Psoriasis is a disease which may have a direct impact on the psychological and social aspects of the patient, particularly due to its visibility. To date, we are unaware of any study showing a relationship between psoriasis and psychological parameters such as psychological vulnerability and coping strategies. OBJECTIVE: The aim of this study was to evaluate the effects of psoriasis on some psychological parameters in an Iranian population. METHODS: Patients having histopathologically confirmed psoriasis for at least 6 months attending the Dermatology Clinic of Razi Hospital were included if they agreed to participate in the study. Patients with history of schizophrenia, major depression or other psychological disorders were excluded. All patients were at least 18 years old. The patients were then referred to the researchers for filling out the appropriate questionnaires under the guidance of an involved psychologist. To evaluate skin involvement, Psoriasis Area Severity Index (PASI) score was calculated and used for all patients. All data were stored in files for further analysis. RESULTS: There were 101 females and 99 males with the mean age of 43.2(±16.32). The mean PASI Score was 6.58 ± 6.04. Diffuse skin involvement was the commonest form of disease (133 patients, 66.5%). The highest score for Illness perception belonged to those with genitalia involvement (185.2, worst illness perception), and the lowest score for Illness perception belonged to those with nail involvement (168.2). Consistently, the lowest score of facing the problems (CISS: approach strategy to disease) belonged to those with hand involvement (50.5) whereas the highest score belonged to those with genitalia involvement (60.4). There was a significant correlation between psychological vulnerability vs. Illness perception score as well as psychological vulnerability vs. coping strategies score. Surprisingly, PASI score had an insignificant relationship with illness perception, coping strategies or psychological vulnerability score. CONCLUSION: PASI score as a representing factor of skin involvement has a limited role in predicting the effect of psoriasis on mental status and illness perception of psoriatic patients. Psychological vulnerability of the patients is the main predicting factor of illness perception and coping strategies (representing patients approach to their disease or their treatment beliefs).
RESUMO
OBJECTIVE: Acne is the most common skin disease and isotretinoin is the most powerful drug among the various drugs used for its treatment, but it has some adverse effects. The aim of this study was to evaluate the effect of isotretinoin on depression and quality of life of a group of patients undergoing isotretinoin therapy before and after the treatment course. METHODS: In this prospective study, 98 patients with severe acne were enrolled consecutively and underwent isotretinoin therapy receiving 0.5 mg/kg/d of isotretinoin for 16 weeks. Isotretinoin effects on quality of life and depression were evaluated using Dermatology Life Quality Index (DLQI) and Beck Depression Inventory (BDI) questionnaires, respectively. RESULTS: In this study, 98 patients suffering from severe acne (38 males and 60 females) were enrolled. Treatment of acne was associated with improvement of quality of life scores in both male and female patients (p = 0.001). Considering the cutoff value of 13 for mild depressive mood in the BDI score, in total, 48 (49%) of the enrolled patients (21 males and 33 females) had a mild depressive mood before the commencement of the treatment in this study. The analysis of before and after treatment BDI scores showed that the number of patients and also the mean score of BDI were increased in both male and female patients after the treatment (p<0.05). CONCLUSION: Isotretinoin therapy improved the quality of life of patients suffering from acne, but depression was accentuated in the patients to some extent.
